Please login to the form below

Zarzio

This page shows the latest Zarzio news and features for those working in and with pharma, biotech and healthcare.

Clock ticking on biosimilar Enbrel in US

In markets outsider the US - where it is known as Zarzio and has been available since 2006 - Sandoz' drug has captured around a 30% share of the Neupogen market.

Latest news

Novartis launches first biosimilar Zarxio in the US

therapies.”. Biosimilars have been available in Europe since 2006 and Zarxio is already available in more than 40 countries under the brand name Zarzio, where it has captured around 30% of
Apotex latest to file Neupogen biosimilar in the US

the brand name Zarzio.
FDA close to first biosimilar approval

US under the brand name Zarzio.
Biosimilars could make EU big cost savings after slow start

In the case of Amgen's once-daily white blood cell stimulator Neupogen (filgrastim), however, the drug has now been overtaken by its biosimilar rivals - led by Sandoz' Zarzio - and the
FDA 'must publish biosimilar naming guide soon'

as Zarzio - in Europe in 2009. ... According to the company Zarzio is the leading G-CSF in Europe with a 30 per cent market share.

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

Customer experience rules the digital age

Establishing an effective customer journey
Embracing digital disruption in pharma

LEO Innovation Lab and some of its successes to date

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Swordfish Advertising

Zarzio. Omnitrope. Adoport. Adoport International. Mezolar Matrix. Pain portfolio. Mometasone. Shire Pharmaceuticals.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager / Account Director: Competative

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Scientific Director / Editorial Team Leader: Great salary and benefits

New Business Director - PR: Competitive Salary and benefits

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Director, Market Access / HEOR - North-West: Negotiable

Senior Medical Writer: Competitive Salary

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Medical Writers Required – Cheshire: DOE

Associate Director: £75, 000-90, 000

Associate Medical Director: Highly Competitive

Events Manager – Med Comms – Surrey: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Account Director: Excellent benefits

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Medical Writer (Remote Working): Competitive Salary Offered

Associate Editorial Director – Med Comms – London: Salary TBC

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Senior Systematic Review Analyst - Oxford: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Medical Writer: Great salary and benefits

Production Manager – Healthcare Communications: DOE

Associate Director, Market Access & HEOR – North-West: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...